223 related articles for article (PubMed ID: 17289347)
1. Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat.
Pitkänen A; Mathiesen C; Rønn LC; Møller A; Nissinen J
Epilepsy Res; 2007 Apr; 74(1):45-54. PubMed ID: 17289347
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
Langer M; Brandt C; Zellinger C; Löscher W
Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
[TBL] [Abstract][Full Text] [Related]
3. Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat.
Pitkänen A; Kharatishvili I; Narkilahti S; Lukasiuk K; Nissinen J
Epilepsy Res; 2005 Jan; 63(1):27-42. PubMed ID: 15716080
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.
Brandt C; Glien M; Gastens AM; Fedrowitz M; Bethmann K; Volk HA; Potschka H; Löscher W
Neuropharmacology; 2007 Aug; 53(2):207-21. PubMed ID: 17585956
[TBL] [Abstract][Full Text] [Related]
5. Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus.
Bankstahl JP; Löscher W
Epilepsy Res; 2008 Nov; 82(1):70-85. PubMed ID: 18760905
[TBL] [Abstract][Full Text] [Related]
6. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
[TBL] [Abstract][Full Text] [Related]
7. Treatment of late lithium-pilocarpine-induced status epilepticus with diazepam.
Gao XG; Liu Y; Liu XZ
Epilepsy Res; 2007 May; 74(2-3):126-30. PubMed ID: 17398071
[TBL] [Abstract][Full Text] [Related]
8. Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain.
Blackburn-Munro G; Bomholt SF; Erichsen HK
Neuropharmacology; 2004 Sep; 47(3):351-62. PubMed ID: 15275824
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study.
Gormsen L; Finnerup NB; Almqvist PM; Jensen TS
Anesth Analg; 2009 Apr; 108(4):1311-9. PubMed ID: 19299805
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus.
Mazarati AM; Baldwin R; Klitgaard H; Matagne A; Wasterlain CG
Epilepsy Res; 2004 Feb; 58(2-3):167-74. PubMed ID: 15120747
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus.
Gibbs JE; Walker MC; Cock HR
Epilepsia; 2006 Mar; 47(3):469-78. PubMed ID: 16529608
[TBL] [Abstract][Full Text] [Related]
12. Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus.
Brandt C; Volk HA; Löscher W
Epilepsia; 2004 Dec; 45(12):1488-97. PubMed ID: 15571506
[TBL] [Abstract][Full Text] [Related]
13. The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy.
François J; Koning E; Ferrandon A; Nehlig A
Epilepsy Res; 2006 Dec; 72(2-3):147-63. PubMed ID: 16945504
[TBL] [Abstract][Full Text] [Related]
14. AMPA receptor desensitization as a determinant of vulnerability to focally evoked status epilepticus.
Fornai F; Busceti CL; Kondratyev A; Gale K
Eur J Neurosci; 2005 Jan; 21(2):455-63. PubMed ID: 15673444
[TBL] [Abstract][Full Text] [Related]
15. Effect of levetiracetam on visual-spatial memory following status epilepticus.
Zhou JL; Zhao Q; Holmes GL
Epilepsy Res; 2007 Jan; 73(1):65-74. PubMed ID: 17029741
[TBL] [Abstract][Full Text] [Related]
16. Differential GABA(A) subunit expression following status epilepticus in seizure-prone and seizure-resistant rats: a putative mechanism for refractory drug response.
Gilby KL; Da Silva AG; McIntyre DC
Epilepsia; 2005; 46 Suppl 5():3-9. PubMed ID: 15987246
[TBL] [Abstract][Full Text] [Related]
17. Progression of brain damage after status epilepticus and its association with epileptogenesis: a quantitative MRI study in a rat model of temporal lobe epilepsy.
Nairismägi J; Gröhn OH; Kettunen MI; Nissinen J; Kauppinen RA; Pitkänen A
Epilepsia; 2004 Sep; 45(9):1024-34. PubMed ID: 15329065
[TBL] [Abstract][Full Text] [Related]
18. Effects of magnesium sulfate in kainic acid-induced status epilepticus.
Mikati MA; Injibar H; Kurdi RM; El Hokayem J; Abou Rialy S; Lteif L; Abdul Jawad M; Francis E; Geha G; Farhat F
J Med Liban; 2006; 54(4):200-4. PubMed ID: 17330372
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus.
Cunha AO; Mortari MR; Liberato JL; dos Santos WF
Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):470-7. PubMed ID: 19371260
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomized, multicentre trial for the treatment of refractory status epilepticus; experiences from evaluating the effect of the novel drug candidate, NS1209.
Sabers A; Wolf P; Møller A; Rysgaard K; Ben-Menachem E
Epilepsy Res; 2013 Sep; 106(1-2):292-5. PubMed ID: 23623849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
